Thyroid cancer risk

The estimated lifetime risk of being diagnosed with thyroid cancer is 1 in 200 (less than 1%) for females, and 1 in 340 (less than 1%) for males born in 1961 in the UK. [1]

These figures take account of the possibility that someone can have more than one diagnosis of thyroid cancer in their lifetime ('Adjusted for Multiple Primaries' (AMP) method).[2]

See also

Lifetime risk for all cancers combined and cancers compared

Thyroid cancer incidence statistics

How risk is calculated

Want to generate bespoke preventable cancers stats statements? Download our interactive statement generator

References

1. Lifetime risk estimates calculated by the Cancer Intelligence Team at Cancer Research UK 2023.
2. Sasieni PD, Shelton J, Ormiston-Smith N, et al. What is the lifetime risk of developing cancer?: The effect of adjusting for multiple primaries  Br J Cancer, 2011.105(3): p.460-5

About this data

Data is for UK, past and projected cancer incidence and mortality and all-cause mortality rates for those born in 1961, ICD-10 C00-C14, C30-C32.

Calculated by the Cancer Intelligence Team at Cancer Research UK, 2023 (as yet unpublished). Lifetime risk of being diagnosed with cancer for people in the UK born in 1961. Based on method from Esteve et al. 1994 [2], using projected cancer incidence (using data up to 2018) calculated by the Cancer Intelligence Team at Cancer Research UK and projected all-cause mortality (using data up to 2020, with adjustment for COVID impact) calculated by Office for National Statistics. Differences from previous analyses are attributable mainly toslowing pace of improvement in life expectancy, and also to slowing/stabilising increases in cancer incidence.

Last reviewed: 14 December 2023

9% of thyroid cancer cases in the UK are preventable.[1]

See also

Want to generate bespoke preventable cancers stats statements? Download our interactive statement generator.

Find out more about the definitions and evidence for this data

Learn how attributable risk is calculated

References

1. Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer 2018.
2. International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 122*. Accessed October 2018.
3. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016 Aug 25;375(8):794-8.
4. World Cancer Research Fund / American Institute for Cancer Research. Continuous Update Project Findings & Reports. Accessed October 2018.

Last reviewed: 14 June 2018

International Agency for Research on Cancer (IARC) classifies the role of this risk factor in cancer development.[1] 8% of thyroid cancer cases in the UK are caused by overweight and obesity.[2]

Thyroid cancer risk is 23% higher per 5-unit body mass index (BMI) increase, an umbrella study of meta-analyses showed.[3]

See also

Learn how attributable risk is calculated

View our statistics on obesity and cancer

View our health information on obesity, weight and cancer

References

1. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016 Aug 25;375(8):794-8.
2. Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer 2018. 
3. Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 2017;:j477.

Last reviewed: 3 May 2019

International Agency for Research on Cancer (IARC) classifies the role of this risk factor in cancer development.[1] 1% of thyroid cancer cases in the UK are caused by ionising radiation.[2]

The highest radiation-associated risks are for those exposed in childhood.[1] Radiation-associated risks may be higher for iodine-deficient people versus those with normal iodine levels.[3]

Radiotherapy

Thyroid cancer risk is 10-15 times higher in people who received a total dose of 10-30 Gray (Gy) of radiotherapy during childhood, compared with the general population a pooled analysis showed.[4] Thyroid cancer risk increases with radiotherapy dose up to around 10Gy, with little if any additional risk beyond this dose; risk also decreases with older age at time of radiotherapy.[4]

Diagnostic radiology

Thyroid cancer risk is not associated with receipt of dental X-rays since 1970, but is 17% higher per 10 dental X-rays received starting before 1970 (when X-ray doses were higher), a cohort study showed.[5]

Thyroid cancer risk is 33-78% higher in people who received computed tomography (CT) scans to the brain, facial bones or spine/neck in childhood, a cohort study showed; CT scans to other body parts were not associated with increased risk.[6]

Atomic bomb radiation

Thyroid cancer risk at age 60 is around 1.3 times higher per 1 Gray (Gy) radiation received, in people exposed to atomic bomb radiation during childhood, compared with the general population, a cohort study showed.[7] Thyroid cancer risk decreases with increasing time since atomic bomb radiation exposure and older age at the exposure; exposure aged 20+ is not associated with thyroid cancer risk.[7]

Thyroid cancer risk among radiological or nuclear accident survivors may be reduced using stable iodine (potassium iodide) to block the thyroid’s uptake of radioactive iodine (iodine thyroid blocking).[8]

See also

Learn how attributable risk is calculated

References

1. International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 122. Accessed October 2018.
2. Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to known risk factors in England, Wales, Scotland, Northern Ireland, and the UK overall in 2015. British Journal of Cancer 2018. 
3. Shakhtarin VV, Tsyb AF, Stepanenko VF, et al. Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. Int J Epidemiol 2003;32(4):584-91.

4. Veiga LH, Lubin JH, Anderson H, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res 2012;178(4):365-76.

5. Neta G, Rajaraman P, Berrington de Gonzalez A, et al. A prospective study of medical diagnostic radiography and risk of thyroid cancer. Am J Epidemiol 2013;177(8):800-9.

6. Mathews JD, Forsythe AV, Brady Z, et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 2013;346:f2360.

7. Furukawa K, Preston D, Funamoto S, et al. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer 2013;132(5):1222-6.

8. Spallek L, Krille L, Reiners C, et al. Adverse effects of iodine thyroid blocking: a systematic review. Radiat Prot Dosimetry 2012;150(3):267-77.

Last reviewed: 1 October 2018

Family history

Thyroid cancer risk is 6.6 times higher in people with a first-degree relative (parent, sibling, child) with the same disease, compared with the general population, a cohort study showed.[1] Familial thyroid cancer risk is higher in people with multiple first-degree relatives affected, relative(s) diagnosed at a younger age, or an affected twin, a cohort study showed.[2]

Genetic factors

Genetic predisposition syndromes account for around 20-25% of medullary thyroid cancers, and around 5–15% of non-medullary thyroid cancers.[3]

Familial adenomatous polyposis (FAP)

Thyroid cancer develops in up to 12% of people with FAP.[4-6]

Cowden syndrome

At least 10% of people with Cowden syndrome develop thyroid cancer in their lifetime.[3,7]

See also

Learn how attributable risk is calculated

See more information on how inherited genes can be a cause of cancer

References

1. Frank C, Fallah M, Ji J, et al. The population impact of familial cancer, a major cause of cancer. Int J Cancer 2014;134(8):1899-906.
2. Fallah M, Pukkala E, Tryggvadottir L, et al. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet 2013;50(6):373-82. 

3. Nosé V. Familial thyroid cancer: a review. Mod Pathol 2011;24 Suppl 2:S19-33.

4. Steinhagen E, Guillem JG, Chang G, et al. The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized. Clin Colorectal Cancer 2012;11(4):304-8.

5. Jarrar AM, Milas M, Mitchell J, et al. Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg 2011;253(3):515-21.

6. Herraiz M, Barbesino G, Faquin W, et al. Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol 2007;5(3):367-73.

7. Pilarski R, Burt R, Kohlman W, et al. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst 2013;105(21):1607-16.

Last reviewed: 1 October 2018

Autoimmune thyroiditis

Autoimmune thyroiditis (Hashimoto’s thyroiditis) is a common cause of hypothyroidism. Around a quarter of patients with papillary thyroid cancer have autoimmune thyroiditis, a meta-analysis showed.[1]

Thyroid nodules

Thyroid cancer risk is higher in people with thyroid nodules, a large case-control study showed.[2] However only around 5% of thyroid nodules identified incidentally by ultrasound are malignant.[3,4]

Thyroid cancer risk among people with thyroid nodules is higher in those with a family history of thyroid cancer, previous radiation exposure, or larger and taller nodules, meta-analyses have shown.[4,5]

Goitre

Thyroid cancer risk is higher in people with goitre (swelling of the thyroid gland); risk may be slightly lower in multinodular versus single nodule goitre.[3,6]

See also

Learn how attributable risk is calculated

References

1. Lee JH, Kim Y, Choi JW, Kim YS. The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. Eur J Endocrinol 2013;168(3):343-9. 

2. Smith-Bindman R, Lebda P, Feldstein VA, et al. Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: results of a population-based study. JAMA Intern Med 2013;173(19):1788-96.

3. Mehanna HM, Jain A, Morton RP, et al. Investigating the thyroid nodule. BMJ 2009;338:b733.

4. Campanella P, Ianni F, Rota CA, et al. Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur J Endocrinol 2014;170(5):R203-11.

5. Brito JP, Gionfriddo MR, Al Nofal A, et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab 2014;99(4):1253-63.

6. Brito JP, Yarur AJ, Prokop LJ, et al. Prevalence of thyroid cancer in multinodular goiter versus single nodule: a systematic review and meta-analysis. Thyroid 2013;23(4):449-55.

Last reviewed: 1 October 2018